• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Butterfly Network, Caption Health Partner on AI-Based Guidance and Diagnostics

Share:

August 16, 2021

What You Should Know:

– Butterfly Networks and Caption Health are partnering to bring life-saving portable AI diagnostic imaging/ultrasound to every medical provider, regardless of their experience.

– Butterfly and Caption’s integrated solution will enhance cardiac assessment by improving the ease of image capture and image interpretation in a variety of care settings including the hospital, clinic, and home. This move can lead to faster diagnosis and treatment for patients with cardiac and respiratory issues resulting from COVID and other diseases.

– Butterfly and Caption Health are expected to introduce the combined platform on Butterfly iQ+ in the United States later this year.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Dariohealth Closes $21.3M to Expand Digital Therapeutics Platform Beyond Diabetes and HypertensionDariohealth Closes $21.3M to Expand Digital Therapeutics Platform Beyond Diabetes and Hypertension
  • Global Gene Therapy Market – Analysis By Vector Type, By Application, By Region, By Country (2020 Edition)Global Gene Therapy Market – Analysis By Vector Type, By Application, By Region, By Country (2020 Edition)
  • Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple MyelomaPfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
  • McKinsey: Up to $250B of Us Health Spending Could Become VirtualMcKinsey: Up to $250B of Us Health Spending Could Become Virtual
  • Zafgen and Chondrial Therapeutics Announce Definitive Merger AgreementZafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
  • Indegene Partners with Amwell to Customized Digital Patient EngagementIndegene Partners with Amwell to Customized Digital Patient Engagement
  • American Well Integrates Telehealth App with Epic EHR Via Epic App OrchardAmerican Well Integrates Telehealth App with Epic EHR Via Epic App Orchard
  • EV Biologics Signs LOI with Lonza Cell & Gene TherapyEV Biologics Signs LOI with Lonza Cell & Gene Therapy

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications